Metraipolis › archive › dc_a73ca3fdae29

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy — Europe PMC PMID:41866628

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41866628
DOI: 10.1002/cam4.71693
License (as archived): solo-consultazione
Archived: 2026-11-05T11:31:51.974Z
SHA-256 of the archived text: 5be5687d92123577dd165830cfcf1a40c0d32a900b18e694a577b1a912594112
Stable URL of this page: https://metraipolis.com/documento/dc_a73ca3fdae29

How to cite

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy — Europe PMC PMID:41866628 — Europe PMC (en), https://europepmc.org/article/MED/41866628 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a73ca3fdae29 (Metraipolis archive dc_a73ca3fdae29, sha256 5be5687d92123577dd165830cfcf1a40c0d32a900b18e694a577b1a912594112)

BibTeX

@misc{dca73ca3fdae29,
  title = {Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy — Europe PMC PMID:41866628},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41866628},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a73ca3fdae29; sha256 5be5687d92123577dd165830cfcf1a40c0d32a900b18e694a577b1a912594112},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41866628. Agents can read the archived copy with the MCP tool read_document.